ABSTRACT:
The pharmaceutical market of Ukraine is characterized by a tendency to dominate imports over exports, which indicates its economic attractiveness for foreign companies that face various obstacles when entering the market. Entry barriers are understood as factors of an objective or subjective nature that prevent new firms from organizing profitable operations in the industry. The presence and impact of market barriers prove the need for their identification and comprehensive research. It has been established that when entering the pharmaceutical market of Ukraine, there are restrictive barriers related to state policy (for example, licensing, registration of medicines, examination, certification, etc.), barriers due to competition, and barriers of a non-legal nature. The results of the analysis of the competitive situation as a possible barrier characterize the pharmaceutical market of Ukraine as a market of free competition, which contributes to the relatively free entry of foreign manufacturers. Market entry barriers are also caused by anti-competitive behavior such as mergers and acquisitions, unfair competition, informal agreements, and so on. The results of the research can be used in making decisions about entering new markets or market segments for pharmaceutical companies, in forming competitive advantages and business strategies in order to develop potential in the long term.
Cite this article:
Elena Shuvanova, Olha Rohulia. The analysis of barriers to entry into the pharmaceutical market of Ukraine. Research Journal of Pharmacy and Technology. 2021; 14(12):6353-8. doi: 10.52711/0974-360X.2021.01098
Cite(Electronic):
Elena Shuvanova, Olha Rohulia. The analysis of barriers to entry into the pharmaceutical market of Ukraine. Research Journal of Pharmacy and Technology. 2021; 14(12):6353-8. doi: 10.52711/0974-360X.2021.01098 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-12-28
REFERENCES:
1. Aleynikova IS, et al. Opredelenie vhodnyih barerov v ekonomicheskoy teorii i praktike antimonopolnoy politiki. Vestnik NGU. Seriya: Sotsialno-ekonomicheskie nauki. T. 11, Vip. 2; 2011. available from: URL: https://lib.nsu.ru/xmlui/bitstream/handle/nsu/3010/11.pdf?sequence=1&isAllowed=y
2. Rejikumar G et al. Pharmaceutical Marketing: Directions for Customer Orientation. Research J. Pharm. and Tech. 2018; 11 (8): 3283-3289. DOI: 10.5958/0974-360X.2018.00604.2
3. Nikita R. Nikam, et al. Generic Vs. Brand Medicines: An Overview. Asian J. of Pharm. Research. 2019; 9 (2): 109-115. DOI: 10.5958/2231-5691.2019.00018.2
4. Pritpal S.B. Global Project Management – Challenges and Barriers. Asian J. of Management. 2018; 9(1): 717-722. DOI: 10.5958/2321-5763.2018.00111.7
5. Bitto B. Barriers that are and that can be faced by current and potential entrepreneurs. Asian J. of Management. 2018; 9(2): 961-966. DOI: 10.5958/2321-5763.2018.00152.X
6. Serbulov YuS, et al. Modelirovanie rinochnih barerov na osnove iskusstvennoy immunnoy sistemi. Lesotehnicheskiy zhurnal. 4 (12); 2013. available from: URL: https://cyberleninka.ru/article/n/modelirovanie-rynochnyh-barierov-na-osnove-iskusstvennoy-immunnoy-sistemy
7. Samborskyi Oleh, et al. Analysis of Stages of Implementation of International Concept of Essential Medicines in the System of Health of Ukraine. Research J. Pharm. and Tech. 2018; 11 (8): 3466-3472. available from: URL: http://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2018-11-8-45
8. Lad P, Muragundi P, Ligade VS. Digitalize Pharmaceutical Marketing: Medical Representative Perspective. Research J. Pharm. and Tech. 2017; 10 (7): 2179-2182. DOI: 10.5958/0974-360X.2017.00384.5
9. Parekh D, et al. Digital Pharmaceutical Marketing: A Review. Research J. Pharm. and Tech. 2016; 9 (1): 108-112. available from: URL: http://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2016-9-1-9
10. Darekar AB et al.. Current Scenario of Global and Indian Pharmaceutical Marketing and Management. Asian J. of Research in Pharm. Sciences. 2016; 6(2): 95-100. DOI: 10.5958/2231-5659.2016.00013.8
11. Kirsanov D. Aptechnyiy rinok Ukraini po itogam 2018 g.: Helicopter View, 2019. available from: URL: https://www.apteka.ua/article/486600
12. Kulitskiy S. Farmatsevtichna galuz i farmatsevtichniy rinok v Ukrayini: stan i problemi rozvitku. Ukrayina: podiyi, fakti, komentari. 6; 2019: 41–53. available from: URL: http://nbuviap.gov.ua/images/ukraine/2019/ukr6.pdf.
13. Investitsii v zdorove: organizatsiya biznesa po proizvodstvu farmatsevticheskoy produktsii. available from: URL: https://kreston-gcg.com/wp-content/uploads/2019/01/20190122-01-2019_farma_cover_fin_pdf_pdf.pdf.pdf
14. Statistichniy zbirnik. Ukrayina u tsifrah. Arhiv. 2018 rik. available from: URL: http://www.ukrstat.gov.ua/druk/publicat/kat_u/2019/zb/11/zb_yearbook_2018.pdf
15. Shimkiv D. Farma — noviy IT dlya Ukrayini. 7 faktov, kotoryie eto dokazyivayut. available from: URL: https://project.liga.net/projects/pharma_innovations/
16. Prohorenko E. Farmatsevticheskiy kongress 2019: kurs na razvitie. available from: URL: https://www.apteka.ua/article/496252
17. Podpruzhnikov Yu. Ukraina uspeshno perevodit farmotrasl na rabotu po evropeyskim standartam GMP. Novosti GMP. 04; 2012. available from: URL: https://gmpnews.ru/2012/04/ukraina-uspeshno-perevela-farmotrasl-na-rabotu-po-evropejskim-standartam-gmp/
18. Panfilova Нanna, et al. The Analysis of Organizational Approaches in Drug Registration in the EU, Ukraine, Tajikistan, Turkmenistan and Uzbekistan. Research J. Pharm. and Tech 2018; 11(5):1894-1900. DOI: 10.5958/0974-360X.2018.00352.9
19. Gubina M. Importozameschenie i/ili eksportnaya orientatsiya: opyit farmatsevticheskoy promyishlennosti Indii. Vestnik SPbGU. Seriya 5: Ekonomika. 2; 2019. available from: URL: https://cyberleninka.ru/article/n/importozameschenie-i-ili-eksportnaya-orientatsiya-opyt-farmatsevticheskoy-promyshlennosti-indii
20. Abramovich N. Seryiy import lekarstvennyih sredstv i meditsinskih izdeliy: sposobi. available from: URL: https://www.legalalliance.com.ua/rus/publikacii/seryj-import-lekarstvennyh-sredstv-i-medicinskih-izdelij-sposoby-protivostoania/
21. Chandra Mouli GV et al. Influence of Personality Factor Contemplations on Individual Occupational Efficiency Optimization: A Strategic and Contextual Assessment. Asian J. of Management. 2014; 5 (1): 14-20. аvailable from: URL: http://ajmjournal.com/HTMLPaper.aspx?Journal=Asian%20Journal%20of%20Management;PID=2014-5-1-3
22. Moroz S, Sahaidak-Nikitiuk R, Zoidze D. Implementation of the Quantitative SWOT Analysis Method in the Research on the Contemporary State and Prospects of Consistent Development of the Pharmaceutical Branch. Research J. Pharm. and Tech. 2019; 12 (11): 5199-5205. DOI: 10.5958/0974-360X.2019.00900.4
23. Kumar PN, Narsi Reddy VV. Degree of Competition in Indian Manufacturing Firms. Asian J. of Management. 2018; 9 (1): 680-684. DOI: 10.5958/2321-5763.2018.00105.1
24. Vasyuta O. Obgruntuvannya spetsifiki vhodzhennya v rinok farmatsevtichnih ta aptechnih pidpriemstv v Ukraini. Biznesinform. 9; 2011: 200–202.